Analysts' average 12-month price target for Smith & Nephew plc is $31.
Get informed when a big investor buys or sells
+ Follow$28.87
2 analysts in the last 4 months
High: $31.85 | Low: $30
No recommendations in the last 4 months.
Smith & Nephew plc (SNN) currently reports a target price of $31. Use the charts on this page to explore Smith & Nephew plc's target price history and peer comparisons.
Analysts' average 12-month price target for Smith & Nephew plc is $31, about 7.1% upside from the current share price of $28.87. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.
Start with the current target price of $31, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Smith & Nephew plc, and consider following SNN for alerts when major investors trade the stock.
Smith & Nephew plc is classified in the Healthcare sector. On target price, it currently shows $31. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SNN with unrelated industries.